1. Home
  2. NPB vs DCTH Comparison

NPB vs DCTH Comparison

Compare NPB & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NPB
  • DCTH
  • Stock Information
  • Founded
  • NPB 1999
  • DCTH 1988
  • Country
  • NPB United States
  • DCTH United States
  • Employees
  • NPB N/A
  • DCTH 76
  • Industry
  • NPB
  • DCTH Medical/Dental Instruments
  • Sector
  • NPB
  • DCTH Health Care
  • Exchange
  • NPB NYSE
  • DCTH Nasdaq
  • Market Cap
  • NPB 449.1M
  • DCTH 426.3M
  • IPO Year
  • NPB 2025
  • DCTH N/A
  • Fundamental
  • Price
  • NPB $14.87
  • DCTH $11.52
  • Analyst Decision
  • NPB Buy
  • DCTH Strong Buy
  • Analyst Count
  • NPB 2
  • DCTH 4
  • Target Price
  • NPB $17.25
  • DCTH $24.00
  • AVG Volume (30 Days)
  • NPB 217.0K
  • DCTH 850.4K
  • Earning Date
  • NPB 01-01-0001
  • DCTH 08-04-2025
  • Dividend Yield
  • NPB 0.66%
  • DCTH N/A
  • EPS Growth
  • NPB 273.19
  • DCTH N/A
  • EPS
  • NPB 1.94
  • DCTH N/A
  • Revenue
  • NPB $195,582,000.00
  • DCTH $53,850,000.00
  • Revenue This Year
  • NPB $27.37
  • DCTH $155.42
  • Revenue Next Year
  • NPB $13.48
  • DCTH $37.93
  • P/E Ratio
  • NPB $7.80
  • DCTH N/A
  • Revenue Growth
  • NPB N/A
  • DCTH 1068.87
  • 52 Week Low
  • NPB $11.43
  • DCTH $7.17
  • 52 Week High
  • NPB $15.50
  • DCTH $18.23
  • Technical
  • Relative Strength Index (RSI)
  • NPB N/A
  • DCTH 32.83
  • Support Level
  • NPB N/A
  • DCTH $12.11
  • Resistance Level
  • NPB N/A
  • DCTH $14.15
  • Average True Range (ATR)
  • NPB 0.00
  • DCTH 0.57
  • MACD
  • NPB 0.00
  • DCTH -0.16
  • Stochastic Oscillator
  • NPB 0.00
  • DCTH 9.67

About NPB NORTHPOINTE BANCSHARES INC

Northpointe Bancshares Inc operates its business through its wholly-owned banking subsidiary, Its lending focus is the origination of residential mortgages throughout the United States. The majority of these loans are sold in the secondary market through a network of investors. The Company has also developed mortgage advance program that provides funding to pre-approved mortgage bankers who originate and sell individual conforming and non-qualified loan products in the secondary market. The Company continues to service loans that were originated and sold to investors as well as loans held in its portfolio which were originated and selectively held in portfolio.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: